257 related articles for article (PubMed ID: 27010985)
1. The properties of the mucus barrier, a unique gel--how can nanoparticles cross it?
Pearson JP; Chater PI; Wilcox MD
Ther Deliv; 2016; 7(4):229-44. PubMed ID: 27010985
[TBL] [Abstract][Full Text] [Related]
2. Coarse-grained modeling of mucus barrier properties.
Gniewek P; Kolinski A
Biophys J; 2012 Jan; 102(2):195-200. PubMed ID: 22339855
[TBL] [Abstract][Full Text] [Related]
3. Undefined role of mucus as a barrier in ocular drug delivery.
Ruponen M; Urtti A
Eur J Pharm Biopharm; 2015 Oct; 96():442-6. PubMed ID: 25770770
[TBL] [Abstract][Full Text] [Related]
4. Barrier properties of gastrointestinal mucus to nanoparticle transport.
Crater JS; Carrier RL
Macromol Biosci; 2010 Dec; 10(12):1473-83. PubMed ID: 20857389
[TBL] [Abstract][Full Text] [Related]
5. Esophageal mucin: an adherent mucus gel barrier is absent in the normal esophagus but present in columnar-lined Barrett's esophagus.
Dixon J; Strugala V; Griffin SM; Welfare MR; Dettmar PW; Allen A; Pearson JP
Am J Gastroenterol; 2001 Sep; 96(9):2575-83. PubMed ID: 11569678
[TBL] [Abstract][Full Text] [Related]
6. The effect of nanoparticle permeation on the bulk rheological properties of mucus from the small intestine.
Wilcox MD; Van Rooij LK; Chater PI; Pereira de Sousa I; Pearson JP
Eur J Pharm Biopharm; 2015 Oct; 96():484-7. PubMed ID: 25758122
[TBL] [Abstract][Full Text] [Related]
7. A free-floating mucin layer to investigate the effect of the local microenvironment in lungs on mucin-nanoparticle interactions.
Wan F; Herzberg M; Huang Z; Hassenkam T; Nielsen HM
Acta Biomater; 2020 Mar; 104():115-123. PubMed ID: 31945503
[TBL] [Abstract][Full Text] [Related]
8. Probing the interaction of nanoparticles with mucin for drug delivery applications using dynamic light scattering.
Griffiths PC; Cattoz B; Ibrahim MS; Anuonye JC
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):218-22. PubMed ID: 25986588
[TBL] [Abstract][Full Text] [Related]
9. Mucin Thin Layers: A Model for Mucus-Covered Tissues.
Rondelli V; Cola ED; Koutsioubas A; Alongi J; Ferruti P; Ranucci E; Brocca P
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362433
[TBL] [Abstract][Full Text] [Related]
10. The role of mucus on drug transport and its potential to affect therapeutic outcomes.
Murgia X; Loretz B; Hartwig O; Hittinger M; Lehr CM
Adv Drug Deliv Rev; 2018 Jan; 124():82-97. PubMed ID: 29106910
[TBL] [Abstract][Full Text] [Related]
11. The oral cavity as a biological barrier system: design of an advanced buccal in vitro permeability model.
Teubl BJ; Absenger M; Fröhlich E; Leitinger G; Zimmer A; Roblegg E
Eur J Pharm Biopharm; 2013 Jun; 84(2):386-93. PubMed ID: 23291061
[TBL] [Abstract][Full Text] [Related]
12. Mucus as a barrier to lipophilic drugs.
Sigurdsson HH; Kirch J; Lehr CM
Int J Pharm; 2013 Aug; 453(1):56-64. PubMed ID: 23727593
[TBL] [Abstract][Full Text] [Related]
13. Mucus as a barrier to drug delivery – understanding and mimicking the barrier properties.
Boegh M; Nielsen HM
Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):179-86. PubMed ID: 25349046
[TBL] [Abstract][Full Text] [Related]
14. Transport properties and aggregation phenomena of polyoxyethylene sorbitane monooleate (polysorbate 80) in pig gastrointestinal mucin and mucus.
Lafitte G; Thuresson K; Jarwoll P; Nydén M
Langmuir; 2007 Oct; 23(22):10933-9. PubMed ID: 17894509
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety concerns over the use of mucus modulating agents for drug delivery using nanoscale systems.
Chater PI; Wilcox MD; Pearson JP
Adv Drug Deliv Rev; 2018 Jan; 124():184-192. PubMed ID: 29247764
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Physicochemical Properties of Native Mucus and Reconstituted Mucin Gels.
Wagner CE; Krupkin M; Smith-Dupont KB; Wu CM; Bustos NA; Witten J; Ribbeck K
Biomacromolecules; 2023 Feb; 24(2):628-639. PubMed ID: 36727870
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier.
Pereira de Sousa I; Cattoz B; Wilcox MD; Griffiths PC; Dalgliesh R; Rogers S; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):257-64. PubMed ID: 25661320
[TBL] [Abstract][Full Text] [Related]
18. Untangling Mucosal Drug Delivery: Engineering, Designing, and Testing Nanoparticles to Overcome the Mucus Barrier.
Watchorn J; Clasky AJ; Prakash G; Johnston IAE; Chen PZ; Gu FX
ACS Biomater Sci Eng; 2022 Apr; 8(4):1396-1426. PubMed ID: 35294187
[TBL] [Abstract][Full Text] [Related]
19. [Gel-forming mucins structure governs mucus gels viscoelasticity].
Demouveaux B; Gouyer V; Magnien M; Plet S; Gottrand F; Narita T; Desseyn JL
Med Sci (Paris); 2018 Oct; 34(10):806-812. PubMed ID: 30451674
[TBL] [Abstract][Full Text] [Related]
20. PEGylation for enhancing nanoparticle diffusion in mucus.
Huckaby JT; Lai SK
Adv Drug Deliv Rev; 2018 Jan; 124():125-139. PubMed ID: 28882703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
